PROCHLORPERAZINE MESYLATE INJ 5MG/ML DIN 00789747
Status: Cancelled Post Market
Holder: SANDOZ CANADA INCORPORATED
Health Canada record
| Active ingredient(s) | PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intramuscular; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AB04 PROCHLORPERAZINE |
| Original market date | 31-Dec-1989 |
| Current status date | 01-Aug-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00753645 | PMS PROCHLORPERAZINE INJ 5MG/ML | PHARMASCIENCE INC | Solution | PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MG | Cancelled Post Market |
| 01927779 | STEMETIL | SANOFI-AVENTIS CANADA INC | Solution | PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MG | Cancelled Post Market |
| 01927787 | STEMETIL LIQ 5MG/5ML | AVENTIS PHARMA INC | Syrup | PROCHLORPERAZINE (PROCHLORPERAZINE MESYLATE) 5 MG | Cancelled Post Market |